These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 26358656)

  • 1. Intracellular delivery of nanocarriers and targeting to subcellular organelles.
    Jhaveri A; Torchilin V
    Expert Opin Drug Deliv; 2016; 13(1):49-70. PubMed ID: 26358656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the study of organelles targeting nanocarriers].
    Sun XY; Wei LL; Chen HL; Liang WQ
    Yao Xue Xue Bao; 2009 Aug; 44(8):838-44. PubMed ID: 20055149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-penetrating peptides with intracellular organelle targeting.
    Cerrato CP; Künnapuu K; Langel Ü
    Expert Opin Drug Deliv; 2017 Feb; 14(2):245-255. PubMed ID: 27426871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited Efficiency of Drug Delivery to Specific Intracellular Organelles Using Subcellularly "Targeted" Drug Delivery Systems.
    Maity AR; Stepensky D
    Mol Pharm; 2016 Jan; 13(1):1-7. PubMed ID: 26587994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.
    Torchilin VP
    Annu Rev Biomed Eng; 2006; 8():343-75. PubMed ID: 16834560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition.
    Chernenko T; Sawant RR; Miljkovic M; Quintero L; Diem M; Torchilin V
    Mol Pharm; 2012 Apr; 9(4):930-6. PubMed ID: 22376068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future of nanotherapeutics: Targeting the cellular sub-organelles.
    Ma X; Gong N; Zhong L; Sun J; Liang XJ
    Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
    Torchilin VP
    AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and Nucleus.
    Munsell EV; Ross NL; Sullivan MO
    Curr Pharm Des; 2016; 22(9):1227-44. PubMed ID: 26675220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanopreparations for organelle-specific delivery in cancer.
    Biswas S; Torchilin VP
    Adv Drug Deliv Rev; 2014 Feb; 66():26-41. PubMed ID: 24270008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides for specifically targeting nanoparticles to cellular organelles: quo vadis?
    Field LD; Delehanty JB; Chen Y; Medintz IL
    Acc Chem Res; 2015 May; 48(5):1380-90. PubMed ID: 25853734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in an active and passive targeting to tumor and adipose tissues.
    Sakurai Y; Kajimoto K; Hatakeyama H; Harashima H
    Expert Opin Drug Deliv; 2015 Jan; 12(1):41-52. PubMed ID: 25376864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ligand nanoparticle conjugation approach for targeted cancer therapy.
    Karra N; Benita S
    Curr Drug Metab; 2012 Jan; 13(1):22-41. PubMed ID: 21892918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
    Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
    Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release.
    Liu J; Cabral H; Mi P
    Adv Drug Deliv Rev; 2024 Apr; 207():115239. PubMed ID: 38437916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.
    Singh D
    Endocr Metab Immune Disord Drug Targets; 2024; 24(13):1480-1487. PubMed ID: 38303531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in galactose-engineered nanocarriers for the site-specific delivery of siRNA and anticancer drugs.
    Jain A; Jain A; Parajuli P; Mishra V; Ghoshal G; Singh B; Shivhare US; Katare OP; Kesharwani P
    Drug Discov Today; 2018 May; 23(5):960-973. PubMed ID: 29129804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
    Qu Q; Ma X; Zhao Y
    Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.